Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Assets: 2019-2025

Historic Assets for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $88.7 million.

  • Biodesix's Assets fell 13.65% to $88.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.7 million, marking a year-over-year decrease of 13.65%. This contributed to the annual value of $97.2 million for FY2024, which is 1.87% down from last year.
  • Latest data reveals that Biodesix reported Assets of $88.7 million as of Q3 2025, which was up 1.12% from $87.7 million recorded in Q2 2025.
  • Biodesix's Assets' 5-year high stood at $115.8 million during Q2 2024, with a 5-year trough of $61.7 million in Q1 2022.
  • Moreover, its 3-year median value for Assets was $87.7 million (2025), whereas its average is $91.8 million.
  • Its Assets has fluctuated over the past 5 years, first surged by 93.35% in 2021, then plummeted by 46.62% in 2022.
  • Biodesix's Assets (Quarterly) stood at $76.1 million in 2021, then rose by 22.09% to $92.9 million in 2022, then climbed by 6.66% to $99.1 million in 2023, then dropped by 1.87% to $97.2 million in 2024, then dropped by 13.65% to $88.7 million in 2025.
  • Its last three reported values are $88.7 million in Q3 2025, $87.7 million for Q2 2025, and $86.2 million during Q1 2025.